Advertisement

ADVERTISEMENT

Partner Approved

Get Eczema Wise During Eczema Awareness Month
Partner Approved
Get Eczema Wise During Eczema Awareness Month
10/16/2020
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Partner Approved
Recognizing Psoriasis in Skin of Color
09/11/2020
Lauren Mateja, Managing Editor
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD details what you need to remember when diagnosing and treating psoriasis in patients of color.
Lynn McKinley-Grant, MD, FAAD...
09/11/2020
The Dermatologist
Tralokinumab: A New Potential for Atopic Dermatitis
Partner Approved
Tralokinumab: A New Potential for Atopic Dermatitis
09/11/2020
Peter Sonnenreich, Contributing Writer
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
New biologic therapy...
09/11/2020
The Dermatologist
Complementary and Alternative Medicines for the Treatment of Atopic Dermatitis
Partner Approved
Complementary and Alternative Medicines for the Treatment of Atopic Dermatitis
08/13/2020
Jonmichael W. Samsel, BS, Courtney E. Heron, BS, Steven R. Feldman, MD, PhD, Sarah L. Taylor, MD, MPH
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
Patients often describe seeking...
08/13/2020
The Dermatologist
Current Considerations in the Treatment of Psoriasis With Phototherapy
Partner Approved
Current Considerations in the Treatment of Psoriasis With Phototherapy
08/13/2020
Joel M. Gelfand, MD, MSCE
Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.
Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.
Phototherapy continues to be a...
08/13/2020
The Dermatologist
COVID-19: A PA’s Practice in Patience
Partner Approved
COVID-19: A PA’s Practice in Patience
08/12/2020
Sarah Patton, MSHS, PA-C
The time away from clinic due to the pandemic has left many with time to contemplate current affairs and their dermatology practice. Sarah Patton, MSHS, PA-C, reflects on how her life and career has changed over the course of 4 months.
The time away from clinic due to the pandemic has left many with time to contemplate current affairs and their dermatology practice. Sarah Patton, MSHS, PA-C, reflects on how her life and career has changed over the course of 4 months.
The time away from clinic due to...
08/12/2020
The Dermatologist
Improving Patient Care: Three Questions With Dr Harper
Partner Approved
Improving Patient Care: Three Questions With Dr Harper
08/12/2020
Lauren Mateja, Managing Editor
In an interview with The Dermatologist, Julie Harper, MD, discussed ways dermatologists can be more proactive in their treatment of rosacea.
In an interview with The Dermatologist, Julie Harper, MD, discussed ways dermatologists can be more proactive in their treatment of rosacea.
In an interview with The...
08/12/2020
The Dermatologist
Recent Research to Consider in the Treatment of Atopic Dermatitis and Eczema
Partner Approved
Recent Research to Consider in the Treatment of Atopic Dermatitis and Eczema
07/15/2020
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to...
07/15/2020
The Dermatologist
A Therapeutic Breakthrough in Treatment Through the Inhibition of IL-17A/IL-17F
Partner Approved
A Therapeutic Breakthrough in Treatment Through the Inhibition of IL-17A/IL-17F
07/15/2020
Lauren Mateja, Managing Editor
Kristian Reich, MD, PhD, discussed a therapeutic breakthrough with bimekizumab, a novel biologic in development that inhibits IL-17F in addition to IL-17A.
Kristian Reich, MD, PhD, discussed a therapeutic breakthrough with bimekizumab, a novel biologic in development that inhibits IL-17F in addition to IL-17A.
Kristian Reich, MD, PhD,...
07/15/2020
The Dermatologist
Breakthroughs in the Pathogenesis and Phenotypic Presentation of Atopic Dermatitis
Partner Approved
Breakthroughs in the Pathogenesis and Phenotypic Presentation of Atopic Dermatitis
06/11/2020
Courtney E. Heron, BS, Rima I. Ghamrawi, BS, Steven R. Feldman, MD, PhD
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that affects 6% to 13% of children and up to 10% of adults in the United States.1,2 This condition commonly emerges in childhood, with up to 85%...
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that affects 6% to 13% of children and up to 10% of adults in the United States.1,2 This condition commonly emerges in childhood, with up to 85%...
...
06/11/2020
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Psych Congress Regionals
July 18 ⁠–⁠ July 19
Advances in Inflammatory Bowel Disease Regionals
July 19 ⁠–⁠ July 20
July 24 ⁠–⁠ July 26
APP Institute Inflammatory Bowel Disease
July 26 ⁠–⁠ July 27
July 27 ⁠–⁠ July 28
July 27 ⁠–⁠ July 28
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 14 ⁠–⁠ August 17
APP Institute Dermatology
August 16 ⁠–⁠ August 17
August 16 ⁠–⁠ August 18
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use